NASDAQ
Ember Therapeutics, Inc. (EMBT) has a free cash flow growth of -296.51% as of Friday, May 29, 2026. This represents a 1605.08% decrease compared to its 12-month average of 19.70%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.